Leap Therapeutics Inc. buy BiotechBee
Start price
07.01.24
/
50%
€3.70
Target price
30.09.25
€5.00
Performance (%)
-18.92%
Price
06.05.24
€3.00
Summary
This prediction is currently active. The price of Leap Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.92%. This prediction currently runs until 30.09.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Leap Therapeutics Inc. | 0.671% | 0.671% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
According to BiotechBee what are the pros and cons of Leap Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Leap Therapeutics Inc diskutieren
Buy mit Kursziel 5,0